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Summary The work presented here has concerned the study of early, as well as late, enzymic changes
occurring during diethylnitrosamine-induced hepatocarcinogenesis and liver regeneration after partial
hepatectomy in comparison with normal liver differentiation. Rank correlation analysis of the enzyme data
suggested a step-wise retrodifferentiation i.e. that the liver during carcinogenesis first assumed a neonatal
enzymic pattern before attaining a foetal enzymic state. Similar enzymic changes were observed in
regenerating liver after partial hepatectomy; again there was a step-wise retrodifferentiation of enzymic
pattern and at 3 days post hepatectomy the liver had an enzymic pattern similar to both foetal and neoplastic
liver. However, in contrast to liver undergoing neoplastic change, the regenerating liver retained the capacity
to undergo redifferentiation towards a normal adult biochemical pattern.
A number of studies have shown neoplastic liver
cells to be similar to foetal liver cells both in terms
of biological appearance and behaviour (Anderson
& Coggin, 1974; Farber, 1976; Enomoto et al.,
1978) and in terms of biochemical markers. Foetal
antigens e.g., a-foetoprotein (Abelev, 1971) and
isoenzymes (Criss, 1971; Schapira, 1973; Ichihara,
1975; Fishman & Singer, 1975) have been shown to
reappear in liver tumours. In his work on the
biochemistry of cancer Greenstein (1954) observed
that "As a whole the metabolic behaviour of
hepatoma and foetal liver is nearly similar and
quite different from that of the nearly similar
metabolic properties of resting adult liver and
regenerating liver after partial hepatectomy."
Collation and statistical analysis of more recent
data from various sources has enabled Knox (1976)
to substantiate this statement.
The resurgence of foetal properties associated
with neoplastic transformation could arise in a
number of ways. The process could be due to the
selection of "stem cells" phenotypically similar to
foetal cells which, instead of undergoing normal
maturation, abnormally differentiate into malignant
cells (Pierce, 1970). Alternatively, embryonic or
partially specialized stem cells may be formed from
adult cells by the action of the carcinogen and then
blocked at any one of a number of stages of re-
ontogeny (Walker & Potter, 1972). Similarly, it has
been suggested that the carcinogen induces a step-
wise retrodifferentiation of mature cells by a
reversal of normal ontogeny (Uriel, 1976).
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Studies to date have largely failed to distinguish
between these mechanisms as most have been
concerned with the tumours themselves rather than
with the early events of carcinogenesis. The work
presented here has involved the histological and
biochemical investigation of both early and late
stages of hepatocarcinogenesis in relation to normal
hepatocyte differentiation, as well as the changes
occurring during liver regeneration following partial
hepatectomy. During normal liver development a
number of enzymes undergo marked changes in
their activity at certain physiologically critical
times: late foetal, neonatal and weaning stages
(Greengard, 1971; Snell, 1981). Nine enzymes which
show such developmental phase-specific profiles of
activity and which were selected entirely on the
basis of their serving as reliable markers of each
critical phase of differentiation were studied during
the course of diethylnitrosamine-induced hepato-
carcinogenesis and during liver regeneration after
partial hepatectomy. For comparison the activity
profiles of these enzymes during normal liver
development were also determined. A number of
considerations governed the selection of the various
enzymes used as differentiation markers in the
present study. It is important to include enzymes
that increase in amount during biochemical
dedifferentiation (foetal enzymes) as well as those
that decrease (adult enzymes) in these
circumstances. This avoids reliance on the loss of
enzyme activities that could well result from non-
specific effects related to the toxicity of the tumour-
inducing chemical or related to non-neoplastic
pathological events occurring in the tissue as a
result of tumour growth. Again, by selecting
enzymes from different pathways of metabolism as
indicators of differentiation there is less chance of a
non-neoplastic change, such as alterations in
nutritional or hormonal status, leading to a
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concerted effect on all enzymes if they serve
different metabolic functions. With a range of
developmental enzyme indicators selected by these
criteria, it is unlikely that any non-specific
physiological or pathological factor would result in
changes in all the enzymes in the direction
characteristic of the dedifferentiated state. Diethyl-
nitrosamine was the carcinogen used in this study
because of its high carcinogenicity and low toxicity
(Magee & Barnes, 1967).
Materials and methods
Wistar Albino rats (from the breeding colony of the
Animal Unit, University of Surrey) were used for
all experiments, except the transplantable hepatoma
studies. Male animals were used for all experiments
except for those on foetal animals (sex not
determined). Two transplantable hepatomas, one
rapidly growing (3 weeks between transplantations)
designated UA, and one more slowly growing (4
weeks between transplantations) designated WDA,
originally induced by ethionine (Reid, 1970), were
passaged by subcutaneous implantation into the
flanks of male Chester Beatty hooded rats (from a
breeding colony at the Animal Unit, University of
Surrey). All animals were allowed food (Laboratory
diet 1, Spratts Patent Ltd., Barking, London, UK)
and water ad libitum.
Diethylnitrosamine (DEN) (Eastman Kodak Co.,
Kirby, Liverpool, UK) was administered in the
drinking water to rats weighing 100-120g at the
beginning of the experiment. DEN-treated animals
gained weight over the course of the experiment
and at any stage were at least 85% of the weight of
age-matched controls. In control animals such
weight differences had a negligible effect on any of
the enzyme activities measured. The concentration
of DEN was adjusted weekly so that the animals
received 10mg DENkg-' body wt per day. This
particular regime gives rise to hepatocellular
carcinomas with a mean induction time of 14 weeks
(Druckrey, 1967; N.J. Curtin, unpublished
observations). Animals were killed at 2, 4, 6, 8, 10
and 11 weeks, and in a preliminary experiment at
15 weeks. Partial hepatectomies (65-70%) were
performed on adult rats in the weight range 150-
250g under ether anaesthesia by the technique of
Higgins & Anderson (1931). Animals were killed
18 h, 24h, 48 h, 3 d, 5 d and 7d after operation.
For hepatic enzyme assays L-malate, glucose 6-
phosphate, ATP, IDP and thymidine were obtained
from Sigma Ltd. (Poole, Dorset, UK). 2-
oxoglutarate, phosphoenolpyruvate, NADH,
glucose 6-phosphate dehydrogenase (from yeast)
and malate dehydrogenase (from pig heart) were
obtained from Boehringer Corporation (Lewes, E.
Sussex, UK). NADP was purchased from
Cambrian Chemicals (Croydon, Surrey, UK) and
NaH"4CO3 (50OpCiml-1; 0.lmCimmol-') and
2-14C thymidine (50pCiml-1; 56.7mCimmol-1)
were obtained from the Radiochemical Centre
(Amersham, Bucks., UK). 5 g of 2,5-
diphenyloxyazole (PPO) and 0.5g of 1,4-bis 2-(5-
phenoxyozole)-benzene (POPOP) from Packard
Instruments Inc. (Downes Grove, Ill., USA) were
dissolved in 11 of toluene as scintillant and for
counting aqueous samples they were dissolved in
667ml of toluene made up to 11 with Metapol or
Synperonic NX detergent (Durham Chemical
Distribution, Birtley, Tyne & Wear, UK). All
remaining chemicals were of Analar grade from
BDH (Poole, Dorset, UK).
Liver or hepatoma tissue for hepatic enzyme
assays was homogenised in 2 vol of ice-cold 0.15 M
KCl-0.2mM KHCO3. Aliquots were diluted with
homogenising medium to give a 10% homogenate,
some of which was then further diluted with
distilled water to give a 1% homogenate. The 1%
homogenate was sonicated for 3 x 10 seconds with a
Soniprobe Type 1130A (Daw Instruments Ltd.,
London, UK). The remaining 33% homogenate was
centrifuged for 1 h at 100,000g at 4°C in an MSE
Superspeed 50 centrifuge. Spectrophotometric
assays were followed using a Gilford 250 spectro-
photometer. Scintillation counting was carried out
in an LKB-Wallac 1210.
Glucose 6-phosphatase (EC 3.1.3.9) was assayed
at 37°C in the 10% homogenate using 25 mM tris-
maleate buffer, pH 6.7, by the method of Nordlie &
Arion (1966). Glutamate dehydrogenase (EC 1.4.1.2)
(Herzfeld, 1972) and aspartate aminotransferase (EC
2.6.1.1) (Herzfeld & Greengard, 1971) were assayed
in the 1% sonicated homogenate at 30°C.
Thymidine kinase (EC 2.7.1.21) was assayed in the
100,000g supernatant at 37°C (Weber et al., 1978)
using Tris-HCl buffer pH 8.0, and phosphoenol-
pyruvate carboxykinase (EC 4.1.1.32) at 30°C
(Ballard & Hanson, 1967). Glucokinase (EC 2.7.1.2)
and hexokinase (2.7.1.1) were assayed in parallel in
the 100,000g supernatant at 30°C (Sharma et al.,
1963). Malic enzyme (EC 1.1.1.40) (Hsu & Lardy,
1969) and glucose 6-phosphate dehydrogenase (EC
1.1.1.44) (Langdon, 1966) were assayed at 30°C in
the 100,000g supernatant.
Results
Enzyme changes in differentiating and regenerating
liver and during hepatocarcinogenesis
The values obtained for liver enzyme activities
during development are given in Table I together
with their designated developmental clusters. TK
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AAT, GDH and G6Pase first appeared in the
foetal period and continued to increase after birth
with adult values achieved at weaning. PEPCK rose
sharply at birth, then gradually decreased to adult
values on weaning. GK and malic enzyme appeared
at weaning. The developmental profiles are in
general agreement with previous studies (see
Greengard, 1971; Knox, 1976; Snell, 1981).
Changes in enzyme activities during the course of
DEN-induced hepatocarcinogenesis are shown in
Table II. From the time of the first observation (at
2 weeks) HK and TK were elevated and all other
enzymes were decreased. G6PDH later increased
above control values so that all three "high foetal
cluster" enzymes were elevated, and enzymes
belonging to more differentiated clusters were
decreased. However malic enzyme, belonging to the
"weaning cluster", was increased orunchanged at the
laterstagesofDENtreatment. ComparisonofTablesI
and II suggests that whereas some of the changes
in enzyme activities during carcinogenesis are similar
to what would be expected from a step-wise
reversal of differentiation (viz. the pattern of
changes in TK, HK, G6PDH and GK), the changes
in activities of the other enzymes did not follow a
strict course of developmental reversal.
Nevertheless, if Spearman's Rank Correlation
analysis is applied to all the data a general pattern
does begin to emerge (Table III). The principles
and applications of this statistical analysis are
explained more fully elsewhere (Knox, 1976).
Briefly, the activities of the enzymes normalized to
liver units (by comparison with values obtained for
control adult animals; where activity in adult liver
is taken as 1.0 liver unit, as recommended by
Knox, 1976) are ranked for each set of observations
(developmental age or time of DEN treatment).
The rank correlation coefficient RS and Student's t-
value being calculated as follows:
6d2
Rs= 1 (n-1)n(n+ 1)
n-2 t=R, 1-R2
where n-2 are the number of degrees of freedom,
d is the difference in rank of each observation
between the two sets and n is the number of
observations. This enables the enzymic pattern in
two different states to be compared.
After 2 weeks of DEN treatment there was no
significant correlation with any stage of
development, however at 4 weeks the liver enzyme
pattern of the treated animals showed a significant
correlation with both the weanling animals
(P<0.01) and the 5-day-old animals (P<0.1). From
6 weeks of DEN treatment onwards the only
significant correlation was with foetal liver
(P<0.05). In the early stages, up to 4 weeks of
treatment with DEN, histological changes were
found to be minimal (N.J. Curtin & K. Snell, in
preparation), and this suggests that the enzymic
changes are unlikely to be due to any toxic effects
of DEN. After 6 weeks of treatment more marked
morphological changes were apparent (viz., fibrosis
and hyperplasia), although the liver was not
classified as preneoplastic on histological grounds at
this stage (N.J. Curtin & K. Snell, in preparation).
The appearance of nodular preneoplastic foci after
10 weeks of DEN treatment was associated with
enzyme changes that were exaggerated in the
nodules (as assessed histochemically) but were not
confined to these focal areas. The enzymic pattern
of primary tumours arising at 15 weeks in this
study showed a significant correlation with the
livers of animals treated for 11 weeks with DEN
alone (P<0.01), and with the WDA transplantable
hepatoma (P<0.01) and the UA transplantable
hepatoma (P<0.05) (results not shown in detail,
see Table VI). There was also a significant
correlation of enzyme patterns of both
transplantable hepatomas with foetal livers P<0.05
and with rats treated for 11 weeks with DEN
(P<0.01 or better) (Table VI).
Changes in enzyme activities during liver
regeneration after partial hepatectomy are shown in
Table IV. Spearman's Rank Correlation analysis
(Table V) shows that at 18 h after hepatectomy
there was a significant correlation with the enzymic
pattern of the weanling rat liver (P<0.05); at 24h
there was a correlation with the 5- and 10-day-old
rat liver (P<0.05); at 48h the hepatectomised liver
showed significant correlations with all stages of
development up to 15 days (P<0.05). At 3 days
after hepatectomy the only correlation was with
foetal rat liver (P<0.005); at 5 days no correlations
were evident; and at 7 days there was a significant
correlation with the 5-day-old rat liver (P<0.05).
Thus it seems that sequential changes in liver
enzymes assume first a postnatal pattern, then a
foetal pattern and then a postnatal pattern again,
i.e. that there is a retrodifferentiation followed by a
redifferentiation. When enzyme profiles in the
hepatectomised rats at 18 and 24h were compared
with DEN-treated rats, the only correlation was
seen with the early stages of carcinogenesis at 4
(P<0.005) and 2 (P<0.05) weeks of DEN
treatment respectively. At 48 h after hepatectomy
there was a correlation with both early stages (2
weeks, P<0.01) and late stages (11 weeks, P<0.05)
of DEN treatment. At 3 days after hepatectomy
there was a correlation with all stages of hepato-
carcinogenesis, the most marked being with 10 and
11 weeks of DEN treatment (P<0.005). After 3
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Table VI Spearman's rank correlation analysis of the enzyme patterns of
transplantable hepatomas and host liver compared with the enzyme
patterns of liver during development, regeneration and primary
hepatocarcinogenesis
UA tumour WDA tumour
Compared
tissue Rs t Rs t
Foetal
Newborn
5 day old
10 day old
15 day old
Weanling
DEN 11 weeks
Host liver in
DEN rats
Tumours in DEN rats
Regenerating liver
18 h p.h.
24 h p.h.
48 h p.h.
3 day p.h.
5 day p.h.
7 day p.h.
0.7042
0.5272
0.5458
0.3708
0.3542
0.5542
2.624*
1.65
1.724
1.056
1.002
1.761
0.7875 3.381**
-0.0208 -0.055
0.7542 3.039*
0.8292
0.6625
0.8958
0.9208
0.8458
0.7875
3.924**
2.34+
5.333***
6.248***
4.195**
3.381*
0.7292
0.3125
0.3167
0.0667
0.2
0.1167
2.819*
0.870
0.883
0.177
0.54
0.311
0.9833 14.31***
-0.1833 -0.493
0.8167 3.744**
0.6167
0.2833
0.6833
0.95
0.7125
0.5833
0.2073+
0.782
2.476*
8.05***
2.687*
1.9+
Statistical significance is given by:
P<0.005.
later stages of hepatocarcinogenesis was no longer
evident while that with early stages remained. There
was a significant correlation of the 3-day post-
hepatectomy liver with both the rapidly growing
UA transplantable hepatoma (P<0.005) and the
slow growing WDA transplantable hepatoma
(P<0.005) (Table VI).
Discussion
The enzymic changes observed during the course of
chronic DEN-induced carcinogenesis and during
liver regeneration are consistent with the view that
these conditions are accompanied by a progressive
return to a foetal enzymic pattern. This adds weight
to the hypothesis of Uriel (1976) that the
development of neoplasia is accompanied by a step-
wise retrodifferentiation of adult cells to immature
cells. However, the conclusions of our study are not
in agreement with those of Malkin et al. (1978)
who stated that there was no evidence for a step-
wise retrodifferentiation or developmental phase-
specific block in the enzymic pattern of either
transplantable hepatomas or primary tumours
induced by DEN plus acetamidofluorene. However
these workers were inconsistent in their choice of
which particular developmental stage (varying from
early foetal to 4 weeks post partum) they used to
represent the enzyme activities characteristic of
immature liver.
The changes in enzyme activity occurred before
marked histological changes were detected and are
unlikely to be a toxic response to DEN. Moreover
the direction of the enzyme changes was the same
as that observed focally at later stages of carcino-
genesis in preneoplastic nodules and later still in the
primary tumours which developed. This persistence
of the nature of the enzyme changes throughout
carcinogenesis and in the final tumours suggests
that the changes are related to the neoplastic
process per se rather than being a feature of a
generalised toxic response. In the absence of
hepatotoxic agents which are unequivocally known
not to be carcinogenic, it was not possible to
investigate the effects of hepatotoxicity directly on
enzyme activities. Nevertheless the fact that
detectable changes are found at an early stage of
carcinogenesis implies that this is a general hepato-
cellular response which only assumes a more focal
nature as carcinogenesis progresses and as
particular groups of cells become "fixed" in the
neoplastic state. Since the enzyme changes appear
to precede any detectable histological features
characteristic of neoplasia, there is the prospect that
the development of such an enzymic pattern may be
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useful as an indicator of in vivo carcinogenesis in
toxicological screening trials, instead of waiting for
the development of frank tumours, thereby
significantly shortening the duration of such trials.
Of the changes observed in regenerating liver the
elevation of PEPCK and decrease in GK activities
have been reported previously (Katz, 1979). These
enzyme adaptations contribute to the metabolic
changes which subserve the need for greater
gluconeogenesis by the small portion of liver
remaining. These authors did not report a decrease
in G6Pase and increase in HK (which would tend
to counteract the enhanced gluconeogenesis) as
observed in the present work. At 3 days after
partial hepatectomy PEPCK activity was lower
than normal (as were the activities of the other
postnatal enzymes) and it was at this time that a
correlation with foetal and neoplastic enzymic
patterns was observed. G6PDH, a key enzyme of
the pentose phosphate pathway, whilst being
elevated in the pre-replicative phase (18 h post-
hepatectomy) was reduced during the period of
most rapid growth. This finding was unexpected as
the pentose phosphate pathway, which generates
NADPH and ribose, is thought to be integral to
DNA synthesis. Longenecker & Williams (1979)
also observed that pentose phosphate pathway
activity was reduced in liver cells after partial
hepatectomy and suggest that' either there is a large
increase in glucose metabolism during regeneration
which ensures sufficient carbon flux through the
pentose phosphate pathway to support the synthesis
of the required nucleic acid precursors, or that
there is no increase and our view of the role of this
pathway must be re-evaluated.
In our study we found that regenerating liver
assumes an enzymic pattern similar to both (pre-)
neoplastic liver and foetal and immature liver,
although contrary views have been expressed (see
Weber, 1975; Knox, 1976). Most previous studies
have centered on regenerating liver at 24h after
partial hepatectomy at which time there is an
underlying synchrony of cell division with most
cells being in the pre-replicative phase and only a
few mitotically active. Much of the liver growth at
this time is due to cellular hypertrophy. The results
reported here confirm that the liver 24h after
partial hepatectomy is different from foetal' and/or
(pre-)neoplastic liver, but that at 3 days post
hepatectomy the regenerating liver bears a strong
enzymic resemblance to foetal and neoplastic liver.
Taken altogether the present results suggest that
an underlying retrodifferentiation process is
common to both the process of hepatocarcino-
genesis and liver regeneration. Although it is
possible that persistent low grade DEN toxicity
could be partly responsible for changes that might
induce the liver to assume a dedifferentiated
enzymic pattern similar to that of regenerating
liver, the fact that the carcinogen treated liver does
not revert to a normal pattern, as in the case of the
regenerating liver, argues that other changes
associated with DEN and related to its
carcinogenicity are responsible for the observed
persistent enzymic dedifferentiation. The working
hypothesis is that whereas preneoplastic
hepatocytes remain trapped in the foetal state
(possibly as a result of the promotion phase of
carcinogenesis), 'the regenerating hepatocytes retain
the capacity to redifferentiate along the normal
pathway of liver development. This interpretation is
consistent with a view expressed previously (Walker
& Potter, 1972) that a fully mature hepatocyte
cannot undergo division without some degree of
dedifferentiation, and that similar stages of
dedifferentiation occur in both regenerating and
precancerous liver. Similarly Uriel (1979) maintains
that tissue regeneration and neoplastic change are
both accompanied by the recapitulation of
ontogeny in a reverse sequence. In the case of
regeneration, as tissue renewal is accomplished
there is a redifferentiation along the same pathway
to give rise to cells showing similar characteristics
to the original cell population.
Although the biochemical resemblance of
neoplastic cells to foetal cells is significant it is by
no means an exclusive feature, as similar
characteristics can be seen in non-cancerous
regenerating cells. Thus, certain "biochemical
markers" of neoplasia, such as increases in a-
foetoprotein, y-glutamyltranspeptidase, G6PDH and
foetal isoenzymes and decreases in G6Pase and
adult isoenzymes, may also be found in
regenerating liver following surgery or toxic injury
(Ideo et al., 1971; Harada et al., 1976; Taketa et al.,
1976; Stillman & Sell, 1979). Since
retrodifferentiation is apparently a process
underlying both neoplastic development and
regeneration, the discovery of markers exclusive to
neoplasia appears to be unlikely. However, the
elevation of PEPCK at most stages of regeneration
and its decrease during the course of carcinogenesis
could possibly be used as a discriminant between
malignant and non-malignant cell replication.
Furthermore our study emphasises that it may be
possible to distinguish between malignant and non-
malignant hyperplasia on the basis of quantitative,
rather than qualitative, differences between these
two states; for, although the pattern of enzyme
activities is similar, the magnitude of change is
greater in the (pre-)neoplastic liver (despite a lesser
degree of hyperplasia and proportion of liver tissue
involved) than in the regenerating liver. A further
degree of resolution might also be achieved by
investigating the levels of isoenzymes of
developmental-phase specific enzymes rather than504 N.J. CURTIN & K. SNELL
total enzyme activity. In the present work this was
not investigated systematically, although the
measurements of hexokinase and glucokinase in
fact distinguish between two groups of glucose
phosphorylating isoenzymes. Since isoenzymes are
by definition the protein products of different
independent genes, their differential expression
during normal liver development and during the
course of hepatocarcinogenesis could provide more
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